NCT03974529

Brief Summary

High quality clinical trial and meta-analysis have demonstrated short term, and to a lesser extent, long term benefits in various outcome measures. To achieve positive effects, supervised progressive strength and aerobic endurance training program of 12 weeks was required. Extended progressive strength training improved muscle strength for up to 24 months. While aerobic endurance training would increase walking capacity up to 16 months. 1 There are data suggesting a threshold of intensity of exercise to be reached for the positive effect. This overall body of evidence suggests that regular vigorous exercise should be accorded a central place in the treatment of Parkinson's disease. However, there was no evidence about regular intensive exercise of running in Parkinson's disease. And most of the studies were not randomized with a control group. In this study, the investigators are to investigate the effect of regular vigorous aerobic exercise training of running on motor and non-motor symptoms, and quality-of-life of people with Parkinson's disease.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at P25-P50 for not_applicable parkinson-disease

Timeline
Completed

Started Dec 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 29, 2018

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 17, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 5, 2019

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2020

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2020

Completed
Last Updated

June 5, 2019

Status Verified

June 1, 2019

Enrollment Period

1.5 years

First QC Date

April 17, 2019

Last Update Submit

June 3, 2019

Conditions

Keywords

Intensive runningGaitBalanceMotor symptoms of Parkinson's diseaseNon-motor symptoms of Parkinson's diseaseUPDRS scorePhysiotherapyQuality of life

Outcome Measures

Primary Outcomes (2)

  • Unified Parkinson's disease rating scale Overall Score

    A comprehensive 50 question assessment of both motor and non-motor symptoms associated with Parkinson's. The MDS-UPDRS features sections that require independent completion by people affected by Parkinson's and their carers, and sections to be completed by the clinician. Part 1: non-motor experiences of daily living Part 2: motor experiences of daily living Part 3: motor examination Part 4: motor complications. Some sections of the UPDRS scale require multiple grades assigned to each extremity with a possible maximum of 199 points. A score of 199 on the UPDRS scale represents the worst (total disability) with a score of zero representing (no disability).

    Six months after finishing the training

  • Parkinson's Disease Questionnaire - 39 (PDQ39) Quality of Life Score

    The PDQ39 is a 39-item self-reporting questionnaire which assess the Parkinson's disease associated health related quality over the last month. PDQ-39 There are 39 questions in the long form Parkinson's Disease Questionnaire, with 8 discrete scales: mobility (10 items) activities of daily living (6 items) emotional well-being (6 items) stigma (4 items) social support (3 items) cognitions (4 items) communication (3 items) bodily discomfort (3 items) Patients are asked to think about their health and general well-being and to consider how often in the last month they have experienced certain events (e.g. difficulty walking 100 yards). Patients are asked to indicate the frequency of each event by selecting one of 5 options (likert Scale): never/occasionally/sometimes/often/always or cannot do at all.

    Six months after finishing the training

Secondary Outcomes (4)

  • Endurance

    Six months after finishing the trainingBaseline, one month after finishing the training, and six months after finishing the training

  • Gait performance

    Six months after finishing the training

  • MiniBest Test Score

    Six months after finishing the training

  • Mood

    Six months after finishing the training

Study Arms (2)

Intensive running arm

EXPERIMENTAL

20 patients will be assigned randomly to intensive running arm (intervention arm). They will be required to complete a designed training protocol.

Behavioral: Intensive running

Physiotherapy arm

ACTIVE COMPARATOR

10 patients will be assigned randomly to physiotherapy arm. They will be required to complete a designed training protocol.

Behavioral: Physiotherapy

Interventions

The patients who are assigned to this group will be required to finish a 90 minutes of training protocol, containing 30 minutes' warm-up stretching, and 60 minutes of supervised progressive aerobic endurance track running. The training takes place two time per week, for 24 weeks.

Intensive running arm
PhysiotherapyBEHAVIORAL

The patients who are assigned to this group will be required to finish a 60 minutes of physiotherapy session. The training takes place once per week, for 24 weeks.

Physiotherapy arm

Eligibility Criteria

Age40 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patient with idiopathic Parkinson's disease, aging from 40 years to 60 years old.
  • Patient who are able to walk independently without walking aids for a distance of 30 meters.

You may not qualify if:

  • Previous history of other neuro-degenerative diseases
  • Presence of ischemic heart disease or musculoskeletal and cardiopulmonary diseases
  • Presence of physical disability
  • History of regular running practice in the past 6 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Chinese University of Hong Kong

Hong Kong, Hong Kong

RECRUITING

Related Publications (3)

  • Mak MK, Wong-Yu IS, Shen X, Chung CL. Long-term effects of exercise and physical therapy in people with Parkinson disease. Nat Rev Neurol. 2017 Nov;13(11):689-703. doi: 10.1038/nrneurol.2017.128. Epub 2017 Oct 13.

    PMID: 29027544BACKGROUND
  • Ernst M, Folkerts AK, Gollan R, Lieker E, Caro-Valenzuela J, Adams A, Cryns N, Monsef I, Dresen A, Roheger M, Eggers C, Skoetz N, Kalbe E. Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2024 Apr 8;4(4):CD013856. doi: 10.1002/14651858.CD013856.pub3.

  • Ernst M, Folkerts AK, Gollan R, Lieker E, Caro-Valenzuela J, Adams A, Cryns N, Monsef I, Dresen A, Roheger M, Eggers C, Skoetz N, Kalbe E. Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2023 Jan 5;1(1):CD013856. doi: 10.1002/14651858.CD013856.pub2.

Related Links

MeSH Terms

Conditions

Parkinson Disease

Interventions

Physical Therapy Modalities

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitation

Study Officials

  • Danny TM Chan, Dr.

    Chinese University of Hong Kong

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The assessment will be taken by three blinded assessors (one occupational therapist, a registered research nurse and a research assistant) at baseline, at completion of the training and 6 months after, at Prince of Wales Hospital.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a prospective randomized controlled single-blinded study. 30 patients will be included and randomized to intervention arm or control arm in a ratio of 2 to 1. Informed consent will be signed after the patient is fully informed about the procedures and prior to the baseline assessments. Intervention arm * Number of participants: 20 * Venue: Shatin playground * Supervisors: licensed coaches (2 to 4 per session) * Training session: 30 minutes of warm-up stretching + 60 minutes supervised progressive aerobic endurance track running * Targeted intensity: 60-75% of maximum heart rate (HR max = 220 - age) OR 40-50% heart rate reserve (HRR= HR max - HR rest) * Frequency and training period: 2 sessions per week, for 24 weeks Control arm * Number of participants: 10 * Venue: Indoor gymnasium * Supervisor: a physiotherapist * Training session: 60 minutes of physical stretching * Frequency and training period: 1 session per week, for 24 weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Neurosurgery, Principal Investigator, Honorary Clinical Professor

Study Record Dates

First Submitted

April 17, 2019

First Posted

June 5, 2019

Study Start

December 29, 2018

Primary Completion

June 30, 2020

Study Completion

December 30, 2020

Last Updated

June 5, 2019

Record last verified: 2019-06

Data Sharing

IPD Sharing
Will not share

Patient do not consent for sharing the data.

Locations